Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-03-12FDA Approved: TOPIRAMATE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for Topiramate from Upsher-Smith Laboratories, LLC. The document indicates an approval action relate…
-
FDA approval · 2025-03-12FDA Approved: TOPAMAX — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for TOPAMAX (topiramate) filed by Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Glioma Intraoperative MicroElectroCorticoGraphy [NA]
A clinical trial update notes a study on Glioma Intraoperative MicroElectrocorticography (iECoG) with conditions Glioma and Epilepsy, curren…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Percutaneous Repair for Drug - Resistant Epilepsy by Intervention of Closing the Patent Foramen Ovale（PREDICT-PFO Trial） [NA]
A clinical trial is evaluating percutaneous closure of patent foramen ovale as a treatment for drug-resistant epilepsy and is currently recr…
-
FDA approval · 2025-03-10FDA Approved: TROKENDI XR — Supplemental Application (Supernus Pharmaceuticals, Inc.)
The FDA approved a supplemental application for TROKENDI XR (topiramate) submitted by Supernus Pharmaceuticals, Inc. The approval updates th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-03-10FDA Approved: LEVETIRACETAM — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for Levetiracetam in Sodium Chloride from Eugia US LLC, adding a salt-form formulation of levetirace…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Prevalence and Pattern of Headache in Pediatric Epilepsy
A clinical trial update from Assiut University examining how prevalent headaches are and their patterns in pediatric epilepsy.
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures [Phase 4]
Phase 4 study evaluating perampanel as monotherapy in untreated participants with focal onset seizures (with or without focal to bilateral t…
-
FDA approval · 2025-03-05FDA Approved: LEVETIRACETAM IN SODIUM CHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for levetiracetam in sodium chloride, a new injectable formulation by Hikma Pharmaceuticals USA Inc.…
-
FDA approval · 2025-03-04FDA Approved: LEVETIRACETAM — Supplemental Application (Actavis Pharma, Inc.)
FDA approves a supplemental application for levetiracetam submitted by Actavis Pharma, Inc.
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Home Ultra-long Term EEG Monitoring for Rare Epilepsies and Developmental and Epileptic Encephalopathies [NA]
Clinical trial update for a study evaluating home ultra-long term EEG monitoring for rare epilepsies and developmental and epileptic encepha…
-
FDA approval · 2025-02-28FDA Approved: OXCARBAZEPINE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for oxcarbazepine from Ascend Laboratories, LLC.
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Neurofeedback Using Implanted Deep Brain Stimulation Electrodes [NA]
A clinical trial is recruiting to evaluate neurofeedback using implanted deep brain stimulation electrodes, sponsored by ETH Zurich, for Par…
-
FDA approval · 2025-02-26FDA Approved: TOPIRAMATE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Topiramate by Ascend Laboratories, LLC (ANDA 217795), resulting in an updated regulatory action …
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: Functional Brain Mapping for Patients with Epilepsy [NA]
A recruiting clinical trial at Wayne State University is investigating functional brain mapping for patients with epilepsy; results not yet …
-
FDA approval · 2025-02-25FDA Approved: LEVETIRACETAM — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for an oral generic formulation of levetiracetam. This approval enables Camber…
-
FDA label_change · 2025-02-25FDA Approved: LEVETIRACETAM — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for levetiracetam from Amneal Pharmaceuticals LLC, resulting in changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Pediatric Language and Memory Mapping in Refractory Epilepsy Using Magnetoencephalography
A pediatric trial evaluating language and memory mapping in children with refractory epilepsy using magnetoencephalography has completed and…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: A Pragmatic Trial of HOBSCOTCH in Georgia [NA]
A pragmatic clinical trial evaluating the HOBSCOTCH program for epilepsy in Georgia has completed.
-
FDA approval · 2025-02-21FDA Approved: LEVETIRACETAM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for LEVETIRACETAM from Ascend Laboratories, LLC under an ANDA, indicating an approved change to an e…
-
FDA approval · 2025-02-21FDA Approved: LEVETIRACETAM — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for the generic levetiracetam product from Eugia US LLC under an ANDA.
-
FDA approval · 2025-02-21FDA Approved: LEVETIRACETAM — Supplemental Application (Prinston Pharmaceutical Inc.)
FDA approved a supplemental application for a generic version of levetiracetam from Prinston Pharmaceutical Inc.
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Biomarker Targeted Stimulation for Epileptiform Events [NA]
A clinical trial from Cadence Neuroscience investigates biomarker-targeted stimulation for epileptiform events in epilepsy; the study is not…
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Cortical Excitability and Treatment Response in People with Epilepsy [NA]
A clinical trial investigating cortical excitability and treatment response in people with epilepsy has completed; sponsor is Stichting Epil…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First Seizure
This clinical trial evaluates how the 2014 ILAE definition of epilepsies affects diagnosis after a first seizure, and recruitment is ongoing…